Soluble CD27 as a predictive biomarker for intra‐tumoral CD70/CD27 interaction in nasopharyngeal carcinoma

Documenti analoghi

• Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer
  di: Michihisa Kono, et al.
  Pubblicazione: (2024)
• Differences in PD‐L1, PD‐L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study
  di: Ryosuke Sato, et al.
  Pubblicazione: (2025)
• Prognostic Value of the 18 F ‐ FDG PET / CT and Haematological Parameters in Head and Neck Cancer
  di: Risa Wakisaka, et al.
  Pubblicazione: (2024)
• Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD‐L1 and PD‐L2
  di: Ryosuke Sato, et al.
  Pubblicazione: (2024)
• Pigments measured at station CD53_27#1
  di: Watson, Andrew J
  Pubblicazione: (2004)